Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resistant hypertension: prevalence and evolving concepts.

Murray Epstein1

  • 1Department of Medicine, University of Miami School of Medicine, Miami, FL, USA. murraye@gate.net

Journal of Clinical Hypertension (Greenwich, Conn.)
|January 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why 25-dehydroxyvitamin D is a negative acute-phase reactant.

Cleveland Clinic journal of medicine·2023
Same author

Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2023
Same author

The constellation of vitamin D, the acute-phase response, and inflammation.

Cleveland Clinic journal of medicine·2023
Same author

Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2022
Same author

Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists-unmet needs and underserved patient cohorts.

Kidney international supplements·2022
Same author

The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets.

Kidney international supplements·2022
Same journal

Acute Left Heart Failure in Twin Pregnancies: Clinical Characteristics and Outcomes-A 10‑Year Retrospective Analysis of 24 Cases.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Visit-to-Visit Systolic Blood Pressure Variability Predicts Long-Term Cardiovascular Events After Coronary Artery Bypass Grafting.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Impact of Maternal Risk Stratification on Clinical Characteristics and Perinatal Outcomes in Singleton Pregnancies With Preeclampsia.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Antihypertensive Efficacy, Safety, and Adherence After Switching From a Free Combination of Bisoprolol/Metoprolol and Amlodipine to Bisoprolol/Amlodipine FDC Tablets (5/5 mg) in Chinese Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Blood Pressure Variability in Acute Ischemic Stroke: Current Evidence, Measurement Challenges, and Future Directions.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Association of Triglyceride-Glucose Index, Triglyceride/HDL Cholesterol Ratio and Metabolic Score for Insulin Resistance With Asymptomatic Organ Damage in Previously Untreated Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
See all related articles

Resistant hypertension, a common disorder, may be more prevalent than previously thought. Aldosterone excess plays a key role in drug resistance, and blocking it effectively treats this condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Resistant hypertension is a significant medical condition, potentially more common than previously estimated based on major clinical trials.
  • Understanding its pathogenesis has advanced with the recognition of aldosterone's critical role.

Purpose of the Study:

  • To highlight the significance of aldosterone in the development of resistant hypertension.
  • To elucidate the complex mechanisms by which aldosterone contributes to elevated blood pressure.
  • To emphasize the therapeutic potential of aldosterone blockade in managing resistant hypertension.

Main Methods:

  • Review of recent outcome studies (e.g., ALLHAT, VALUE, CONVINCE).
  • Analysis of postulated mechanisms of aldosterone-induced hypertension.

Related Experiment Videos

  • Examination of extrarenal effects of aldosterone on vascular smooth muscle.

    • Main Results:

    • Aldosterone excess is increasingly recognized as a key factor in drug-resistant hypertension.
    • Aldosterone contributes to hypertension through both sodium retention and direct vascular effects.
    • Extrarenal mechanisms include direct vasoconstriction and altered vascular compliance.

    Conclusions:

    • Aldosterone blockade is an effective strategy for treating resistant hypertension.
    • Understanding aldosterone's multifaceted role is crucial for managing this condition.
    • Further research into aldosterone's vascular effects may refine treatment approaches.